July 2026
The global cardiovascular drugs market size is valued at USD 155.96 billion in 2025 and is expected to hit around USD 221.20 billion by 2035, growing at a CAGR of 3.56% from 2026 to 2035.
September 2026
The U.S. cardiovascular drugs market was valued at USD 29.25 billion in 2026, with leading companies including Bristol-Myers Squibb, Bayer AG, Pfizer Inc.
July 2026
The global lipid-lowering drugs market size was evaluated at USD 35.46 billion in 2025 and is projected to attain around USD 49.65 billion by 2035 with a CAGR of 3.42%.
March 2026
The global intravenous iron drugs market size was valued at USD 3.84 billion in 2025 and is expected to attain around USD 8.82 billion by 2035 at a CAGR of 8.67%.
March 2026
The global muscle relaxant drugs market size is estimated to hit around USD 7.64 billion by 2035 increasing from USD 4.80 billion in 2025, with a CAGR of 4.76%.
February 2026
The global antitussive drugs market size was evaluated at USD 1.72 billion in 2025 and is predicted to hit around USD 2.86 billion by 2035, growing at a CAGR of 5.23%.
November 2025
The global duchenne muscular dystrophy drugs market size is projected to hit around USD 19.46 billion by 2034, increasing from USD 4.79 billion in 2025, with a CAGR of 16.85%.
July 2025
The omega 3 prescription drugs market size was valued at USD 1.44 billion in 2024 and is projected to hit around USD 2.93 billion by 2034 with a CAGR of 7.36%.
July 2025
The global fibrate drugs market size was valued at USD 3.42 billion in 2024 and is projected to attain around USD 5.67 billion by 2034 with a CAGR of 5.19%.
September 2026
The asthma drugs market was valued at USD 27.87 billion in 2026 and is expected to hit around USD 42.74 billion by 2035, growing at a CAGR of 4.46% from 2026 to 2035.
September 2026
The global generic drugs market size is estimated at USD 491.67 billion in 2026 and is projected to reach USD 762.48 billion by 2035 at a 5% CAGR, driven by rising demand for affordable medicines and patent-expired drugs.
August 2026
The genitourinary drugs market size was USD 30.37 billion in 2026, with leading genitourinary drugs market players including Pfizer inc, johnson & johnson, bayer ag, Sanofi.
July 2025
The global acute migraine treatment market size was valued at USD 3.46 billion in 2024 and is expected to surge around USD 10.08 billion by 2034 with a CAGR of 11.30%.
September 2026
The global injectable peptides drugs market size was evaluated at USD 53.07 billion in 2026 and is predicted to hit around USD 117.18 billion by 2035, growing at a CAGR of 9.20%.
August 2026
The global cardiovascular devices market size is expected to increase from USD 74.71 billion in 2025 to hit around USD 158.41 billion by 2035, with a CAGR of 7.81%.
August 2026
The oncology/cancer drugs market size is calculated at USD 192.39 billion in 2025 and is projected to hit around USD 554.69 billion by 2035 with a CAGR of 11.17%.
August 2026
The global head and neck cancer drugs market size surpassed USD 18.78 billion in 2025 and is projected to hit around USD 36.48 billion by 2035 with a CAGR of 6.87%.
July 2026
The global cardiovascular ultrasound market size reached USD 3.01 billion in 2025 and is projected to surpass around USD 5.61 billion by 2035 with a CAGR of 6.42%.
July 2026
The global over the counter (OTC) drugs market size is expected to increase from USD 135.25 billion in 2025 and is expected to hit USD 256.87 billion by 2035, growing at a CAGR of 6.62%
July 2026
The global immunotherapy drugs market size was valued at USD 318.83 billion in 2025 and is projected to hit around USD 1,607.94 billion by 2035, with a solid CAGR of 17.56%.
July 2026
The lyophilized injectable drugs market size was valued at USD 397.17 billion in 2025 and is expected to attain around USD 1,516.32 billion by 2035, with a CAGR of 14.34%.
July 2026
The global cephalosporin drugs market size was calculated at USD 20.65 billion in 2025 and is projected to attain around USD 27.69 billion by 2035, with a CAGR of 2.98%.
July 2026
The global oxycodone drugs market size was valued at USD 7.06 billion in 2025 and is projected to reach around USD 12.10 billion by 2035 with a CAGR of 5.54%.
July 2026
The global general anesthesia drugs market size was calculated at USD 5.60 billion in 2025 and is projected to surpass around USD 8.06 billion by 2035, with a CAGR of 3.71%.
July 2026
The global 3D printed drugs market size was estimated at USD 338.28 million in 2024 and is predicted to reach around USD 789.20 million by 2034 with a CAGR of 8.84%.
June 2026
The global epigenetic drugs market size is anticipated at USD 16.22 billion in 2025 and is predicted to hit around USD 92.57 billion by 2035, growing at a CAGR of 19.03%.
June 2026
The U.S. multiple sclerosis drugs market size is estimated to hit around USD 18.43 billion by 2035 increasing from USD 8.44 billion in 2025, with a CAGR of 8.12%.
June 2026
The global PD-1 inhibitor drugs market size was estimated at USD 48.69 billion in 2025 and is expected to hit around USD 201.87 billion by 2035, growing at a CAGR of 15.28% from 2026 to 2035.
June 2026
The global orphan drugs market size was surpass to USD 216.55 billion in 2025 and is projected to reach around USD 676.59 billion by 2035 with a CAGR of 12.07%.
June 2026
The global atherosclerosis drugs market size is projected to hit around USD 25.07 billion by 2035, increasing from USD 17.60 billion in 2025, with a CAGR of 3.60%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com